# Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research

> **NCT06049381** · — · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 22 (estimated)

## Conditions studied

- Relapsed Non-Hodgkin Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06049381
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06049381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06049381, "Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06049381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*